Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 60,117 | 42,794 | 62,680 | 56,220 | 36,421 |
| Operating Income | -60,117 | -42,794 | -62,680 | -56,220 | -36,421 |
| Interest Expense | 1,926 | 2,071 | 1,694 | 1,742 | 1,904 |
| Other Income | 6,192 | 7,323 | 2,350 | 185 | 292 |
| Pre-tax Income | -55,851 | -37,543 | -62,025 | -57,776 | -38,033 |
| Income Tax | N/A | N/A | N/A | N/A | -479 |
| Net Income Continuous | -55,851 | -37,543 | -62,025 | -57,776 | -37,554 |
| Net Income | $-55,851 | $-37,543 | $-62,025 | $-57,776 | $-37,554 |
| EPS Basic Total Ops | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 |
| EPS Basic Continuous Ops | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 |
| EPS Diluted Total Ops | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 |
| EPS Diluted Continuous Ops | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 |
| EBITDA(a) | $-61,538 | $-42,546 | $-62,469 | $-55,955 | $-35,890 |